Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nanocarriers: more than tour de force for thymoquinone.
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto TJA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Rathore C, et al. Among authors: dua k. Expert Opin Drug Deliv. 2020 Apr;17(4):479-494. doi: 10.1080/17425247.2020.1730808. Epub 2020 Feb 20. Expert Opin Drug Deliv. 2020. PMID: 32077770 Review.
Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices.
Ramanunny AK, Wadhwa S, Gulati M, Singh SK, Kapoor B, Dureja H, Chellappan DK, Anand K, Dua K, Khursheed R, Awasthi A, Kumar R, Kaur J, Corrie L, Pandey NK. Ramanunny AK, et al. Among authors: dua k. Eur J Pharmacol. 2021 Jan 5;890:173691. doi: 10.1016/j.ejphar.2020.173691. Epub 2020 Oct 28. Eur J Pharmacol. 2021. PMID: 33129787 Review.
Can dextran-based nanoparticles mitigate inflammatory lung diseases?
Prasher P, Sharma M, R Wich P, Jha NK, Singh SK, Chellappan DK, Dua K. Prasher P, et al. Among authors: dua k. Future Med Chem. 2021 Dec;13(23):2027-2031. doi: 10.4155/fmc-2021-0218. Epub 2021 Oct 1. Future Med Chem. 2021. PMID: 34596425 No abstract available.
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models.
Tan CL, Chan Y, Candasamy M, Chellian J, Madheswaran T, Sakthivel LP, Patel VK, Chakraborty A, MacLoughlin R, Kumar D, Verma N, Malyla V, Gupta PK, Jha NK, Thangavelu L, Devkota HP, Bhatt S, Prasher P, Gupta G, Gulati M, Singh SK, Paudel KR, Hansbro PM, Oliver BG, Dua K, Chellappan DK. Tan CL, et al. Among authors: dua k. Eur J Pharmacol. 2022 Mar 15;919:174821. doi: 10.1016/j.ejphar.2022.174821. Epub 2022 Feb 11. Eur J Pharmacol. 2022. PMID: 35151643 Review.
824 results